Main > A1. CORP. INDEX. C-Cm No. 1 > Cerus Corp./P C2
Cerus Corp./P C2's subsections
2001. 06.06. Hemato.
2007. 11.20. ImmunoTherapy
2009. 08.19. CH Approval
2010. 04.06. Oxford Finance Corp
2010. 08.24. BioOne Corp.
2010. 09.02. Swiss Red X
2010. 09.07. WPI
2010. 09.23. USA DOD Award
2010. 09.27. 3-Year French Study
2010. 10.12. Dist. AU & NZ: CSL Ltd
2011. 06.29. Changes in BoD
2012. 01.09. CBO
2012. 09.11. Hemato.>TTP
2012. 10.25. CLO
2012. 12.04. Swiss Red X
2014. 11.21. Ebola
2014. 12.16. INTERCEPT Plasma Syst.
2016. 06.19. INTERCEPT Red Blood
2016. 08.29. Zika Risk Reduction
2020. 03.26. COVID-19
2022. 11.01. CA Approval
2024. 03.26. FDA Approval
Web-Site
Cerus Corp./P C2's products
This section has no products